Abstract
Atherosclerotic lesions in the great arteries are frequent findings in the elderly. Numerous studies have shown their strong predictive value for cardiovascular disease, embolic events, and mortality. We sought to determine the risk of all-cause mortality depending on the localization of plaques in the thoracic aorta evaluated by transesophageal echocardiography (TEE). A total of 2,054 patients (median age 65 years, interquartile range 52–73; 58% men) who underwent a TEE examination between 01/2007 and 03/2015 were retrospectively analyzed. For each patient, the presence of atherosclerotic lesions in the ascending aorta, the aortic arch, and in the descending aorta, as well as cardiovascular risk factors and survival were documented. Median follow-up period was 48 months (interquartile range 38–58). Multivariate Cox regression analysis indicated plaque in the ascending aorta (HR of 1.36, 95% CI 1.01–1.83, P = 0.046), the aortic arch (HR of 1.78, 95% CI 1.29–2.45, P < 0.001), the descending aorta (HR of 2.01, 95% CI 1.54–2.77, P < 0.001), and plaque in any part of the thoracic aorta (HR of 1.84, 95% CI 1.42–2.4, P < 0.001), as independent predictors for all-cause mortality after adjusting for age, sex, arterial hypertension, hyperlipidemia, smoking, and diabetes. In this study, we could demonstrate that more than mild plaque at any site of the thoracic aorta predicts all-cause mortality. Assessment of atherosclerotic lesions in all segments of the thoracic aorta should be part of every routine TEE examination.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Atherosclerosis and its cardiovascular sequelae represent the leading cause of death globally.
A common manifestation of systemic atherosclerosis is atheroma of the thoracic aorta, a well-acknowledged cause of embolic events [1,2,3]. Numerous studies have shown the strong correlation of severe thoracic aortic plaque and cerebrovascular events [4], especially in patients with cryptogenic or recurrent stroke [5]. Complex and large (> 4 mm) plaques have a particularly high risk for embolism [6]. Furthermore, aortic atheroma is associated with the presence of aortic stenosis [7], atrial fibrillation [8], mitral annular calcification [9], carotid artery disease [10], and coronary artery disease [11]. One small study showed that plaque in the descending aorta predicts cardiovascular events [12], another showed the prognostic value of large plaque lesions in the aortic arch [13].
It is well recognized that plaque may occur at any level of the thoracic aorta and its prevalence increases with age [14]. However, the Stroke Prevention: Assessment of Risk in a Community (SPARC) study identified the descending aorta as the most prevalent site of aortic atherosclerosis (34.4%) followed by the aortic arch (25.6%). The ascending aorta was only affected in 6.2% of included patients [15]. So far, no studies have explored the plaque extent in different levels of the thoracic aorta with long-term survival.
Although there has been evidence for plaque in the thoracic aorta as a risk factor for long-term survival, it is poorly understood whether even small plaque detected in TEE predicts mortality in an unselected population.
We sought to investigate the prognostic value of plaque assessed with TEE depending on its localization in the thoracic aorta.
Methods
Study design, patient selection, and data acquisition
We conducted a retrospective single center cohort study to identify the impact of plaque in the thoracic aorta on all-cause mortality. All patients who received a TEE at our institution between 01/2007 and 03/2015 and where plaque location and extent in the thoracic aorta were clearly stated in the written report were included in the study. The primary endpoint was defined as all-cause mortality. Survival until 12/31/2017 was documented via the “Statistik Austria” death registry. Survival time was calculated from the date of the TOE examination until 12/31/2017 in all patients. Patient demographics, medical diagnoses, and daily medication were retrieved from the centralized patient management system of Vienna (AKIM- AKH-Informationsmanagement). The following clinical data were collected: age, sex, presence of arterial hypertension, dyslipidemia, diabetes mellitus, smoking, and cardiovascular medications (oral anticoagulants, antiplatelet medication, ACE inhibitors/ AT1 blocker, beta blockers, diuretics). Smoking was defined as no-smoker or as current/ former smoking habit. The study was approved by the ethics committee of the Medical University of Vienna (No. 1725/2016) and complies with the 1975 declaration of Helsinki (Fig. 1).
Echocardiography
TEE data was retrieved from our echocardiography documentation system. All included patients underwent a complete standardized examination performed by cardiologists experienced in this modality. The plaque extend was assessed by visual estimation and reported as no plaque, mild plaque, mild to moderate plaque, moderate plaque, moderate to severe plaque, and severe plaque. Since data analysis included examinations from a time period of eight years, plaque extent was neither judged by the same readers nor was there a single definition of cut-offs regarding plaque size or plaque thickness. To minimize interobserver variability, we did not differentiate between different degrees of plaque but compared presence or absence of relevant plaque (Fig. 2). Previous studies revealed no increased mortality risk in patients with small plaque [16]. To establish the two study groups relevant and non-relevant plaque, we therefore counted no plaque and mild plaque as non-relevant, any degree of plaque more than mild was counted as relevant plaque.
The thoracic aorta was divided into three segments: the ascending aorta (proximal the brachiocephalic artery), the aortic arch (between the origin of the brachiocephalic and the left subclavian artery) and the descending aorta (distal from the left subclavian artery).
Statistical analysis
Continuous data are given as median and standard deviation (SD). Discrete data are presented as counts and percentages. Multivariate Cox proportional hazards regression analysis was applied to assess the association between atheroma in the different segments of the thoracic aorta with all-cause mortality. The regression models were adjusted for the following confounders: age, sex, arterial hypertension, diabetes, hyperlipidemia, and smoking. Schoenfeld residuals was calculated to check the proportional hazards assumption. Kaplan Meier Curves are presented for survival analysis. Unpaired student’s t-test was applied to compare categorical data. A P value of < 0.05 was considered statistically significant. Statistical analyses were performed using SPSS Version 24 (IBM SPSS, USA).
Results
Baseline characteristics
A total of 2054 patients were included in the study, 58% were male. Median age was 65 years (interquartile range 52–73). All patients underwent a complete TEE study. Cardiovascular risk factors were significantly present with 62% suffering from arterial hypertension, 41% had hyperlipidemia, 15% suffered from diabetes mellitus, and 31% were former or active smokers. Cardiovascular risk factors as well as cardiovascular medication were significantly more frequently present in patients with than in those without atheromatosis. Detailed baseline characteristics of all patients are displayed in Table 1.
Echocardiographic findings
The thoracic aorta was assessed in all patients. Of the 2054 included patients, 42% had more than mild plaque at any level of the thoracic aorta, 13% had plaque in the ascending aorta, 32% in the aortic arch, and 23% in the descending aorta. The group of patients which did not survive 4-year follow-up had significantly higher numbers of atheromatosis than the group that survived (Table 2).
Prediction of long-term mortality
Over a median follow-up period of four (SD ± 2,2) years, 17% of patients died. Kaplan–Meier curves for all-cause mortality are shown in Fig. 1.
In a multivariate cox regression analysis adjusting for age, sex, arterial hypertension, hyperlipidemia, smoking, and diabetes, plaque in the thoracic aorta remained independently associated with a dismal outcome regardless of the plaque location (Table 3).
Discussion
The present study demonstrates that more than mild plaque in any of the segments of the thoracic aorta is independently associated with a dismal outcome.
Prognostic value of plaque
Plaque in the thoracic aorta is a common finding in the routinely performed transesophageal echocardiogram, especially in the elderly [17]. An association with cardiovascular risk factors has been demonstrated previously [18]. In the present study, we showed an association with hypertension, diabetes mellitus, dyslipidemia, and smoking.
Most previous studies used severe plaque (> 4/5 mm) as the cut-off and did not take smaller plaque into account [2, 19]. Limited data are available regarding the association of smaller plaque in the thoracic aorta detected by TEE with all-cause mortality. Previous studies were mostly limited to cardiac surgery cohorts [8, 20], patients with coexisting atrial fibrillation [13], or used other modalities such as computed tomography [20] or transthoracic echocardiography [21, 22]. Ferrari et al. demonstrated in a prospective study including 129 patients, that even small plaques (1–3.9 mm) are associated with embolic events and mortality in an unselected population [21]. With our data, we can confirm these findings in a large cohort. Multivariate analysis demonstrated significant prognostic power for all three segments of the thoracic aorta independent of age, sex, and cardiovascular risk factors. Kaplan–Meier curves revealed a significantly elevated mortality risk for patients with plaque in any region of the thoracic aorta.
Different plaque regions
The distribution of plaque along the thoracic aorta in our cohort was similar to previously published reports, which described the arch and the descending aorta as the more frequently affected sites when compared to the ascending aorta [15]. One hypothesis to explain this phenomenon is the differing wall sheer stress along the thoracic aorta [22].
An observational study including more than 22,000 patients demonstrated that plaque of any size in the descending and ascending aorta is a significant risk factor for long-term survival in cardiac surgery patients [23]. However, to the best of our knowledge, ours is the first study to analyze the impact of plaque in the three segments of the thoracic aorta on all-cause mortality in an unselected large population. There are several reports describing the impact of plaque in the different locations of the aorta on cardiovascular diseases. Atheroma in the ascending aorta and the aortic arch are considered main risk factors for stroke [5]. Patients with aortic arch atheroma were shown to have a similar stroke prevalence as patients with atrial fibrillation and carotid stenosis [24]. Furthermore, plaque in the proximal thoracic aorta is considered a major risk factor for recurrent stroke [5] and embolic events related to cardiac procedures (TAVI, cardiac surgery) [23, 25]. Plaque in the descending aorta can also be an indicator for systemic atherosclerotic disease. This assumption is supported by the fact that there is a strong association with age and cardiovascular risk factors [26], and with coronary artery disease [11]. Further investigations are needed to clarify a possible causal link of plaque in the descending aorta with embolic events and mortality.
The knowledge of plaque extent and distribution has several clinical implications. Aortic atheroma is strongly associated with cardiovascular risk factors. Therefore, secondary prevention with optimal treatment of arterial hypertension, diabetes mellitus, and dyslipidemia as well as smoking cessation are of even more importance in this patient group. The knowledge about plaque burden may furthermore provide information to anticipate the patient’s risk for embolic events and mortality during cardiac procedures. Finally, Ferrari et al. were able to demonstrate the superiority of anticoagulation versus antiplatelet therapy in patients with severe aortic plaque (> 4 mm). However, they did not show a beneficial effect in the group with plaque size of 1–3.9 mm [21]. Further studies are necessary to clarify the optimal management of these patients.
Limitations
The present study has several limitations. The data collection was retrospective; the reported values were exported from the hospital’s database and not confirmed by an independent echocardiographer. Our data reflects the experience of a single tertiary care center. However, the potential advantage of a single-center approach is the consistent quality of imaging. We included all consecutive patients undergoing TEE into our study regardless of age, indication, and medical history. However, a cohort with an indication for TEE is not comparable to the general population. Plaque extend in our cohort was assessed by visual estimation by different cardiologists. To minimize this potential limitation, we did not differentiate between different degrees of plaque but compared presence or absence of relevant plaque.
The assessment of the aorta via transesophageal echocardiography is limited by the “blind spot”, which refers to a small area of the distal ascending aorta which cannot be seen due to the interposition of the air-filled trachea between the esophagus and the aorta [27, 28]. In addition, especially in the distal ascending aorta, the aortic arch, and in the proximal descending aorta, due to the proximity of the probe to the aorta, there can be a near field drop out artefact of the aortic wall close to the probe. Even though there are some regions which cannot or can only partly be evaluated, nevertheless the most of the three parts of the aorta are accessible in most patients and give a representative impression on the degree of overall calcification.
Conclusion
In this study, we could demonstrate that more than mild plaque at any site of the thoracic aorta predicts all-cause mortality. Assessment of atherosclerotic lesions in all segments of the thoracic aorta should be part of every routine TEE examination.
References
Tunick PA, Kronzon I (1990) Protruding atherosclerotic plaque in the aortic arch of patients with systemic embolization: a new finding seen by transesophageal echocardiography. Am Heart J 120(3):658–660
Montgomery DH, Ververis JJ, McGorisk G, Frohwein S, Martin RP, Taylor WR (1996) Natural history of severe atheromatous disease of the thoracic aorta: a transesophageal echocardiographic study. J Am Coll Cardiol 27(1):95–101
Tunick PA, Rosenzweig BP, Katz ES, Freedberg RS, Perez JL, Kronzon I (1994) High risk for vascular events in patients with protruding aortic atheromas: a prospective study. J Am Coll Cardiol 23(5):1085–1090
Harloff A, Simon J, Brendecke S, Assefa D, Helbing T, Frydrychowicz A et al (2010) Complex plaques in the proximal descending aorta: an underestimated embolic source of stroke. Stroke 41(6):1145–1150
Katsanos AH, Giannopoulos S, Frogoudaki A, Vrettou AR, Ikonomidis I, Paraskevaidis I et al (2016) The diagnostic yield of transesophageal echocardiography in patients with cryptogenic cerebral ischaemia: a meta-analysis. Eur J Neurol 23(3):569–579
Sen S, Hinderliter A, Sen PK, Simmons J, Beck J, Offenbacher S et al (2007) Aortic arch atheroma progression and recurrent vascular events in patients with stroke or transient ischemic attack. Circulation 116(8):928–935
Osranek M, Pilip A, Patel PR, Molisse T, Tunick PA, Kronzon I (2009) Amounts of aortic atherosclerosis in patients with aortic stenosis as determined by transesophageal echocardiography. Am J Cardiol 103(5):713–717
Okura H, Inoue H, Tomon M, Nishiyama S, Yoshikawa T, Yoshida K (1999) Transesophageal echocardiographic detection of cardiac sources of embolism in elderly patients with ischemic stroke. Intern Med 38(10):766–772
Adler Y, Vaturi M, Fink N, Tanne D, Shapira Y, Weisenberg D et al (2000) Association between mitral annulus calcification and aortic atheroma: a prospective transesophageal echocardiographic study. Atherosclerosis 152(2):451–456
Hueb JC, Bazan R, Pereira Braga G, Fusco DR, Zanati Bazan SG, Bojikian MB (2013) Carotid artery atherosclerotic profile as a predictor of the aorta atherosclerotic profile in patients with cerebrovascular events. Cerebrovasc Dis 36(1):26–32
Gu X, He Y, Li Z, Kontos MC, Paulsen WH, Arrowood JA et al (2011) Relation between the incidence, location, and extent of thoracic aortic atherosclerosis detected by transesophageal echocardiography and the extent of coronary artery disease by angiography. Am J Cardiol 107(2):175–178
Varga A, Gruber N, Forster T, Piros G, Havasi K, Jebelovszki E et al (2004) Atherosclerosis of the descending aorta predicts cardiovascular events: a transesophageal echocardiography study. Cardiovasc Ultrasound 2:21
Okura H, Kataoka T, Yoshiyama M, Yoshikawa J, Yoshida K (2013) Aortic atherosclerotic plaque and long-term prognosis in patients with atrial fibrillation-a transesophageal echocardiography study. Circ J 77(1):68–72
Dávila-Román VG, Phillips KJ, Daily BB, Dávila RM, Kouchoukos NT, Barzilai B (1996) Intraoperative transesophageal echocardiography and epiaortic ultrasound for assessment of atherosclerosis of the thoracic aorta. J Am Coll Cardiol 28(4):942–947
Meissner I, Whisnant JP, Khandheria BK, Spittell PC, O'Fallon WM, Pascoe RD et al (1999) Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc 74(9):862–869
Hartman GS, Yao FS, Bruefach M, Barbut D, Peterson JC, Purcell MH et al (1996) Severity of aortic atheromatous disease diagnosed by transesophageal echocardiography predicts stroke and other outcomes associated with coronary artery surgery: a prospective study. Anesth Analg 83(4):701–708
Zhou C, Qiao H, He L, Yuan C, Chen H, Zhang Q et al (2016) Characterization of atherosclerotic disease in thoracic aorta: a 3D, multicontrast vessel wall imaging study. Eur J Radiol 85(11):2030–2035
Amarenco P, Cohen A, Tzourio C, Bertrand B, Hommel M, Besson G et al (1994) Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 331(22):1474–1479
Izumi C, Takahashi S, Miyake M, Sakamoto J, Hanazawa K, Yoshitani K et al (2010) Impact of aortic plaque morphology on survival rate and incidence of a subsequent embolic event–long-term follow-up data. Circ J 74(10):2152–2157
Santos RD, Rumberger JA, Budoff MJ, Shaw LJ, Orakzai SH, Berman D et al (2010) Thoracic aorta calcification detected by electron beam tomography predicts all-cause mortality. Atherosclerosis 209(1):131–135
Ferrari E, Vidal R, Chevallier T, Baudouy M (1999) Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: benefit of oral anticoagulants. J Am Coll Cardiol 33(5):1317–1322
Malek AM, Izumo S (1994) Molecular aspects of signal transduction of shear stress in the endothelial cell. J Hypertens 12(9):989–999
Butler CG, Ho Luxford JM, Huang CC, Ejiofor JI, Rawn JD, Wilusz K et al (2017) Aortic Atheroma Increases the Risk of Long-Term Mortality in 20,000 Patients. Ann Thorac Surg 104(4):1325–1331
Macleod MR, Amarenco P, Davis SM, Donnan GA (2004) Atheroma of the aortic arch: an important and poorly recognised factor in the aetiology of stroke. Lancet Neurol 3(7):408–414
Kahlert P, Knipp SC, Schlamann M, Thielmann M, Al-Rashid F, Weber M et al (2010) Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 121(7):870–878
Katsanos AH, Giannopoulos S, Kosmidou M, Voumvourakis K, Parissis JT, Kyritsis AP et al (2014) Complex atheromatous plaques in the descending aorta and the risk of stroke: a systematic review and meta-analysis. Stroke 45(6):1764–1770
Evangelista A, Flachskampf FA, Erbel R, Antonini-Canterin F, Vlachopoulos C, Rocchi G et al (2010) Echocardiography in aortic diseases: EAE recommendations for clinical practice. Eur J Echocardiogr 11(8):645–658
Patil TA, Nierich A (2016) Transesophageal echocardiography evaluation of the thoracic aorta. Ann Card Anaesth 19:S44–S55
Acknowledgement
Open access funding provided by Medical University of Vienna.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors have read and approved submission of the manuscript and have no conflict of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary file1 (MP4 3519 kb)
Supplementary file2 (MP4 3475 kb)
Supplementary file3 (MP4 3011 kb)
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Heidari, H., Ran, H., Spinka, G. et al. Atherosclerotic plaque detected by transesophageal echocardiography is an independent predictor for all-cause mortality. Int J Cardiovasc Imaging 36, 1437–1443 (2020). https://doi.org/10.1007/s10554-020-01840-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10554-020-01840-6